Muzzi E, Zennaro B, et al: J Laryngol Otol 2010; 124 (February): e2 Patients who receive hyperbaric oxygen after failing standard treatment for sudden sensorineural hearing loss may have some improvement.
Intratympanic Gentamicin Is Reasonable Tx for Ménière's With Near-Normal Hearing

Intratympanic Gentamicin Treatment of Patients With Ménière's Disease With Normal Hearing.
Silverstein H, Wazen J, et al: Otolaryngol Head Neck Surg 2010; 142 (April): 570-575 Intratympanic gentamicin has acceptable rates of vertigo control and hearing preservation in patients with Ménière's disease, even those with near-normal hearing.
Background: Ménière's disease has been known for almost 150 years, but treatment strategy remains controversial. Classic symptoms include low-frequency hearing loss, tinnitus, aural fullness, and usually, most bothersome, episodic vertigo. Although gentamicin is associated with hearing loss, with a reasonable dosing regimen, the risk to hearing is small. Objective: To describe the outcome of intratympanic (IT) gentamicin for Ménière's disease with near-normal hearing. Design: Retrospective review. Participants: 256 consecutive patients who underwent gentamicin therapy for Ménière's between 1996 and 2007. A total of 224 patients had at least 24 months of follow-up. Patients were stratified into 2 groups by hearing status: those with pure tone averages (PTAs) <25 dB and those with >25 dB. Methods: All patients were treated using the Silverstein MicroWick system. Gentamicin was self-administered by patients at a dose of 10 mg/mL as 3 drops 3 times/day after an initial infusion of 0.2 mL of this gentamicin solution. Treatment was stopped when patients no longer had a response to ice water calorics or if gentamicin failed to decrease the vestibular response for 2 consecutive weeks. Questionnaires were used to assess health status and vertigo control. Results: Only 24 patients (11%) had a PTA better than 25 dB. This group averaged 51 years of age and was predominately female. Average PTA and speech discrimination score (SDS) decrease was 8 dB and 3% in this group, with one third of patients having a significant decrease in PTA (>10 dB). Asymmetry in vestibular responses increased during treatment, and 71% of these patients had class A or B vertigo control. There was a larger group of 200 patients who had a PTA worse than 25 dB. In this group, PTA decreased by an average of 11 dB, and 42% had a significant decrease in SDS. Class A or B vertigo control was achieved in 75%. In this group, 16 patients underwent further therapy that included either a vestibular nerve section or labyrinthectomy. Conclusions: Ménière's patients with near-normal hearing treated with intratympanic gentamicin had rates of hearing loss and vertigo control similar to that in the group of patients with worse hearing. Reviewer's Comments: The study falls short in a few respects. First, there was no control group, which is a notorious problem in evaluating Ménière's therapy since a significant fraction of these patients improve without therapy. Second, the group of patients with near-normal hearing was small. Finally, hearing loss is one of the diagnostic criteria for Ménière's disease, so it is possible that those with more mild hearing loss may have lesssevere vertigo symptoms or symptoms due to other causes. (Reviewer-Benjamin T. Crane, MD). Combining surgical excision with preoperative and postoperative external beam radiotherapy appears to be an effective treatment option for earlobe keloids.
Combined Surgical Excision, Radiotherapy Decreases Recurrence Rate of Keloids
Background: Keloids are often resistant to various treatment modalities and have a high recurrence rate. The earlobe is one of the anatomical body areas prone to keloids and can form after ear piercing, trauma, infection, or other insults to the tissue. Keloids are more common in patients with darker skin between the ages of 10 and 30 years. Treatment modalities include pressure therapy, cryotherapy, intralesional steroids, surgical excision, radiation, topical silicone, and laser.
Objective: To present the authors' experience with treating earlobe keloids utilizing extralesional excision combined with preoperative and postoperative radiation therapy. Design/Methods: Patients treated between 1996 and 2005 with the "sandwich" technique were retrospectively reviewed. All patients underwent extralesional excision of the earlobe keloid and external beam radiotherapy delivered in 2 fractions the day before and after surgery. The irradiation field consisted of the lesion site with 1.0 cm normal margins. The total dose was 10.0 to 12.5 Gy in all patients. The minimal follow-up period was 6 months and included a subjective patient satisfaction assessment as well as documentation of keloid recurrence or cure.
Results: 23 patients with 29 earlobe keloids were treated in the study. Average age was 24 years and included 57% males. Keloid lesion size ranged from 0.5 to 2.5 cm with a mean of 1.93 cm. Ear piercing was the predominant inciting event, seen in 65% of patients. Eight patients (35%) had failed previous treatments and were categorized as the high-risk group. The average follow-up period was 3.47 years. The recurrence rate was 25% for the low-risk group and 27% for the high-risk group. Patient satisfaction in those without recurrence was high. Conclusions: Combining surgical excision with preoperative and postoperative external beam radiotherapy appears to be an effective treatment option for earlobe keloids. Reviewer's Comments: Keloids are relatively resistant to treatment, with high recurrence rates using a single treatment modality. The best treatment strategy for keloid is prevention. Surgical excision alone in the treatment of earlobe keloids has been cited to have a recurrence rate of nearly 80%. Radiation alone in the treatment of keloids has seen variable success rates. However, excision followed by radiation therapy has been reported to have a recurrence rate as low as 10% to 20%. Hence, further investigations are needed to determine if the addition of preoperative radiotherapy in the "sandwich" technique is warranted compared to combined surgical excision with postoperative radiotherapy alone. (Reviewer-Tang Ho, MD). Transantral endoscopic repair of orbital blowout fractures is a safe and predictable approach in selected patients.
Transantral Endoscopic Orbital Floor Fracture Repair Shows Long-Term Stability
Background: Approaching the orbital floor for repair of blowout fractures has traditionally been done through various lower eyelid incisions. The transantral endoscopic approach for orbital floor fracture repair, first described in the 1950s, offers the potential advantages of better visualization of implant placement and avoiding the complications associated with lower eyelid approaches.
Objective: To present long-term follow-up results of the authors' transantral endoscopic repair of orbital blowout fractures. Participants/Methods: Retrospective analysis of 32 patients over a 10-year period (1998 to 2008). Methods: 28 patients required actual reconstruction of the orbital floor and the rest required exploration and repositioning of orbital contents only. In total, 17 were reconstructed with titanium mesh and 11 were repaired with Medpor implants. Surgery was performed within 2 weeks for 25 patients (78.1%). Mean follow-up duration was 27.5 months (range, 4 months to 10 years).
Results: There were 21 male and 11 female patients. Half of the patients were injured in motorcycle accidents. Sixteen patients (50%) had associated zygomaticomaxillary complex (ZMC) fractures. Reduction of the ZMC fracture was performed prior to endoscopic evaluation and repair of the orbital floor blowout fracture. Four of 5 patients with associated medial orbital wall fractures underwent medial orbital wall reconstruction at the same time. Twenty-five patients (78.1%) had documented enophthalmos, and diplopia was present in 15 patients (46.9%). All patients had successful repair of the fractures. Two patients had residual enophthalmos of 1 mm postoperatively and 4 patients had residual diplopia after repair. Conclusions: Transantral endoscopic approach for the repair of orbital floor fractures is safe and reliable in selected patients. Long-term follow-up showed stability of surgical results. Reviewer's Comments: As otolaryngologists, we are especially familiar with the use of endoscopes and maxillary sinus anatomy. Hence, the expected learning curve may be shorter for otolaryngologists employing transantral endoscopic approach for orbital floor fracture repair. This approach may be particularly useful in the acute setting where there may be significant eyelid edema present. Although not specifically mentioned in the study, the endoscopic approach may be particularly useful in blowout fractures that extend more posteriorly along the orbital floor, which would require more dissection with the traditional lower eyelid incisional approaches. (Reviewer-Tang Ho, MD). Fat injection laryngoplasty seems to be effective in enhancing acoustic and quality of life outcomes in patients with unilateral vocal cord paralysis.
Patients With Vocal Cord Paralysis Satisfied With Fat Injection Medialization
Outcomes of Fat Injection Laryngoplasty in Unilateral Vocal Cord Paralysis.
There are many modalities of vocal fold medialization for vocal fold paralysis, and one that is still used worldwide is fat injection. There are 2 problems with fat medialization. One is that another incision is required for harvesting of fat. More importantly, in 2007 McCulloch et al, reported that the failure rate is 30% within 2 years, and fat graft has not been favored by some laryngologists in the United States. However, the long-term benefit of fat graft injection is still unclear. Objective: To report on the authors' series on fat injection medialization. Design: Longitudinal outcomes evaluation study. Methods: Essentially, this is a case series on 32 patients who have undergone fat injection for unilateral vocal fold paralysis with preoperative and serial postoperative follow-up at Chang Gung Memorial Hospital in Taipei, Taiwan. The follow-up time is 1 year, and the patients were followed with a quality of life survey as well as several acoustic variables. Results: According to this report, the patients improved in terms of voice-related quality of life as well as in several acoustic variables.
Conclusions: Fat injection has adequate outcomes for unilateral vocal cord paralysis.
Reviewer's Comments: The rationale behind the renaissance of fat injection laryngoplasty is possibly due to its relative ease of use in comparison to framework type I laryngoplasty. Moreover, other forms of medialization require the incorporation of material into the larynx with potential for complications associated with foreign body insertion. Furthermore, the studies from McCulloch et al, that demonstrated the increased failure rate of fat injection laryngoplasty was not a controlled study. Dr Fang and colleagues therefore described their review of their experience with fat injection. Comparing the McColloch study with the current study, the McColloch paper stated that the mean time to failure of fat injection was around 160 days, but in this current paper, the failure rate, as measured by a Taiwanese version of voice outcome survey, was slightly over 10%. Now, this report does not mention the number of revision surgeries over their series, which is probably the best measure of success. This paper does include objective acoustic variables in their population, but acoustic variables have not correlated with functional assessment of one's own voice. One possibility that explains the differences in result may stem from how the fat injection was performed between the 2 groups. Regardless, most agree that fat resorption is a real problem. The authors themselves suggest that the improvement in jitter and straining is probably due to fat resorption. The final take-home message from this paper is that fat injection may be a sufficient method for voice improvement, but its long-term effect is still unknown. (Reviewer-Young J. Kim, MD).
How Common Are Medication Errors in Surgical Patients?
Perioperative Medication Errors in Otolaryngology. Rosenwasser R, Winterstein AG, et al: Laryngoscope 2010; 120 (June): 1214 120 (June): -1219 Several types of medication errors were found in this study, and the rate of errors was about 3% of surgical cases.
Background: Medication errors are a common cause of complications and poor outcomes. Although there are now several layers in place to try to prevent these types of errors in most institutions, they continue to occur, and information on these types of errors is scarce. Objective: To identify the causes and types of medication errors in the perioperative setting. Design: Prospective study. Participants: 589 patients who underwent surgery. Methods: During a 2-month period in 2008, all physicians and nurses were encouraged to report any event that might be considered a perioperative medication-related error. These errors could occur in clinic, the operating department, or at the patient's home. The staff was educated on the types of medication errors through a 45-minute presentation. A $10 incentive was provided for reporting errors and practitioners were sent frequent email reminders. A second part of the study involved a full-time observer who sought out medication errors related to otolaryngology cases. Results: 589 surgeries were performed during the study period. A total of 20 medication errors were identified. Errors occurred preoperatively, intraoperatively, and postoperatively. The most common error was wrong dosage, followed by omitted dose, wrong drug, wrong site, and unnecessary medication in order of frequency. Most dosage errors occurred due to lack of experience or training. No errors caused any harm to the patient. The authors believe that improvements in electronic medication ordering might be able to prevent some medication errors. Conclusions: Medication errors are common throughout the otolaryngology perioperative period. Reviewer's Comments: This study demonstrates that there is a high rate of medication errors made in the perioperative period, although none of the errors reported had an adverse effect on the patient. This study has some inherent biases because it largely relies on self-reported errors, thus some errors may not have been reported. Also, the professionals involved knew they were being studied so they might have been more careful than usual in avoiding some types of errors. The study concludes that many of these errors could have been avoided with a better electronic medication ordering system. Although these systems have advantages, this study does not directly show that they decrease the number of medication errors. (Reviewer-Benjamin T. Crane, MD).
